Xcout IntelSign inSubscribe

Excellergy competitors & alternatives

BiotechnologyUnited States

The 12 closest competitors and alternatives to Excellergy among biotechnology companies — ranked by similarity to what Excellergy actually does, not by market-cap band.

12Competitors listed

Subscribe to see Excellergy’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Excellergy

Excellergy is a biotechnology company developing a new therapeutic class known as Effector Cell Response Inhibitors (ECRIs) to treat severe allergic diseases. Its trifunctional mechanism aims to provide rapid and complete control of allergic responses by removing bound IgE from effector cells, neutralizing circulating free IgE, and downregulating receptor expression.

Excellergy at a glance

Excellergy is a biotechnology company headquartered in United States. Xcout tracks 8 named people at Excellergy, including TODD ZAVODNICK (Chief Executive Officer).

Excellergy leadership

  • TODD ZAVODNICKChief Executive Officer
  • Phil BrownChief Medical Officer
  • Geoff HarrisChief Scientific Officer & Co-Founder
  • Luke PenningtonVice President, Discovery & Co-Founder
  • Alex EggelCo-Founder
  • Ted JardetzkyCo-Founder

2 more named people on record for Excellergy, with roles, board committees and tenure — see the full roster →

Recent Excellergy news

Top 12 Excellergy competitors

Ranked by semantic similarity — how close each company is to Excellergy by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Excellergy and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Excellergyand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →